The use of audit to improve clinical effectiveness in an infrequent obstetric therapy: Magnesium sulphate in severe pre-eclampsia

Scottish Medical Journal

Volumn 43, Issue 5, 1998, Pages 151-153

  Taylor, G M ^a,b   McKenzie, C A ^a   Mires, G J ^a  

^a NINEWELLS HOSPITAL   (United Kingdom)

^b UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

Audit; Clinical effectiveness; Magnesium sulphate; Pre eclampsia

Indexed keywords

MAGNESIUM SULFATE;

ARTICLE; CLINICAL ARTICLE; CLINICAL PROTOCOL; DRUG EFFICACY; DRUG MONITORING; FEMALE; HUMAN; MEDICAL AUDIT; PREECLAMPSIA;

EID: 0031785924     PISSN: 00369330     EISSN: None     Source Type: Journal    
DOI: 10.1177/003693309804300510     Document Type: Article

References (7)

1. Eclampsia Trial Collaborative Group. Which anticonvulsant for women with eclampsia? Evidence from the Collaborative Eclampsia Trial. Lancet 1995; 345: 1455-63
2. RCOG Guideline No. 10. Management of Eclampsia. RCOG 1996
3. Duley L, Gulmezoglu AM, Henderson-Smart DJ. Anticonvulsants for women with severe pre-eclampsia. In: Neilson JP, Crowther CA, Hodnett ED, Hofmeyr GJ (eds.) Pregnancy and Childbirth module of The Cochrane Database of Systematic Reviews [updated 02 December 1997]. The Cochrane Library. The Cochrane Collaboration; Issue 1. Oxford: Update Software; 1998
4. Chein PFW, Khan KS, Arnott N. Magnesium Sulphate in the treatment of eclampsia and pre-eclampsia: an overview of the evidence from randomised trials. Br J Obstet Gynaecol 1996; 103: 1085-91
5. Smith GCS, McEwan HP. Use of magnesium sulphate in Scottish obstetric units. Br J Obstet Gynaecol 1997; 104: 115-16
6. Robson SC. Magnesium sulphate: the time of reckoning Br J Obstet Gynaecol 1996; 103: 99-102
7. Sibai BM, Graham JM, McCubbin JH. A comparison of intravenous and intramuscular magnesium sulfate regimens in pre-eclampsia. Am J Obstet Gynecol 1984; 150: 728-33